Todd W Vanderah

Professor Todd W. Vanderah is a distinguished expert in the field of neuropharmacology, serving as the Department Head of Pharmacology at the University of Arizona College of Medicine. With a multifaceted academic role, he is also a Professor of Anesthesiology, Neurology, Neuroscience, and Physiological Sciences, and is affiliated with the BIO5 Institute. His extensive expertise is further highlighted by his dual Co-Directorships of the MD/PhD Dual Degree Program and the Comprehensive Pain and Addiction Center. Dr. Vanderah's research in neuropharmacology spans over two decades, during which he has made significant contributions to the field. His work has been consistently recognized and supported by the National Institutes of Health (NIH), ensuring a steady stream of funding since his initial appointment. His prolific research output includes 170 peer-reviewed publications, reflecting his commitment to advancing scientific knowledge and understanding in his areas of interest. In addition to his research endeavors, Dr. Vanderah is an accomplished author, having written three textbooks on neuroscience. These works serve as valuable resources for students and professionals alike, underscoring his dedication to education and the dissemination of knowledge. His academic journey began at the University of Arizona, where he earned his PhD in Pharmacology and Toxicology, laying the foundation for his illustrious career. Dr. Vanderah's leadership and expertise have been instrumental in shaping the future of pharmacology and neuroscience at the University of Arizona. His contributions extend beyond research and education, as he actively mentors the next generation of scientists and healthcare professionals. His commitment to excellence and innovation continues to inspire those around him, making him a respected figure in his field. Through his work, Dr. Vanderah has made a lasting impact on the understanding and treatment of neurological disorders, pain management, and addiction. His dedication to improving patient outcomes and advancing medical science is evident in every aspect of his career, making him a true leader in the field of neuropharmacology.